ReviewTranslational breast cancer research : a journal focusing on translational research in breast cancer2025

Trastuzumab deruxtecan in patients with bone metastases from HR+/HER2-low breast cancer: efficacy enhanced by denosumab.

Azzurra Irelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.